annual CFF:
$56.00M+$1.43B(+104.07%)Summary
- As of today (May 21, 2025), MRNA annual cash flow from financing activities is $56.00 million, with the most recent change of +$1.43 billion (+104.07%) on December 31, 2024.
- During the last 3 years, MRNA annual CFF has risen by +$929.00 million (+106.41%).
- MRNA annual CFF is now -97.25% below its all-time high of $2.03 billion, reached on December 31, 2020.
Performance
MRNA Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$4.00M+$7.00M(+233.33%)Summary
- As of today (May 21, 2025), MRNA quarterly cash flow from financing activities is $4.00 million, with the most recent change of +$7.00 million (+233.33%) on March 31, 2025.
- Over the past year, MRNA quarterly CFF has dropped by -$10.00 million (-71.43%).
- MRNA quarterly CFF is now -99.71% below its all-time high of $1.38 billion, reached on June 30, 2020.
Performance
MRNA quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$46.00M-$10.00M(-17.86%)Summary
- As of today (May 21, 2025), MRNA TTM cash flow from financing activities is $46.00 million, with the most recent change of -$10.00 million (-17.86%) on March 31, 2025.
- Over the past year, MRNA TTM CFF has increased by +$867.00 million (+105.60%).
- MRNA TTM CFF is now -97.74% below its all-time high of $2.03 billion, reached on December 31, 2020.
Performance
MRNA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MRNA Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +104.1% | -71.4% | +105.6% |
| 3 y3 years | +106.4% | +100.6% | +103.0% |
| 5 y5 years | +7.7% | -99.3% | -92.7% |
MRNA Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +101.6% | -88.2% | +100.3% | -17.9% | +101.2% |
| 5 y | 5-year | -97.3% | +101.6% | -99.7% | +100.3% | -97.7% | +101.2% |
| alltime | all time | -97.3% | +101.6% | -99.7% | +100.3% | -97.7% | +101.2% |
MRNA Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $4.00M(-233.3%) | $46.00M(-17.9%) |
| Dec 2024 | $56.00M(-104.1%) | -$3.00M(-127.3%) | $56.00M(-212.0%) |
| Sep 2024 | - | $11.00M(-67.6%) | -$50.00M(-58.0%) |
| Jun 2024 | - | $34.00M(+142.9%) | -$119.00M(-85.5%) |
| Mar 2024 | - | $14.00M(-112.8%) | -$821.00M(-40.4%) |
| Dec 2023 | -$1.38B(-60.1%) | -$109.00M(+87.9%) | -$1.38B(-19.3%) |
| Sep 2023 | - | -$58.00M(-91.3%) | -$1.71B(-36.6%) |
| Jun 2023 | - | -$668.00M(+23.2%) | -$2.69B(-19.7%) |
| Mar 2023 | - | -$542.00M(+23.7%) | -$3.35B(-2.9%) |
| Dec 2022 | -$3.45B(+295.0%) | -$438.00M(-57.9%) | -$3.45B(-11.2%) |
| Sep 2022 | - | -$1.04B(-21.6%) | -$3.88B(+36.5%) |
| Jun 2022 | - | -$1.33B(+106.7%) | -$2.84B(+84.6%) |
| Mar 2022 | - | -$642.00M(-26.5%) | -$1.54B(+76.5%) |
| Dec 2021 | -$873.00M(-142.9%) | -$873.00M(>+9900.0%) | -$873.00M(-2084.1%) |
| Sep 2021 | - | -$2.00M(-91.7%) | $44.00M(-42.1%) |
| Jun 2021 | - | -$24.00M(-192.3%) | $76.00M(-94.9%) |
| Mar 2021 | - | $26.00M(-40.9%) | $1.48B(-27.2%) |
| Dec 2020 | $2.03B(+3809.6%) | $44.00M(+46.7%) | $2.03B(+0.6%) |
| Sep 2020 | - | $30.00M(-97.8%) | $2.02B(+0.7%) |
| Jun 2020 | - | $1.38B(+138.9%) | $2.01B(+218.6%) |
| Mar 2020 | - | $578.00M(+1722.3%) | $629.71M(+1111.0%) |
| Dec 2019 | $52.00M(-95.8%) | $31.72M(+100.6%) | $52.00M(-91.3%) |
| Sep 2019 | - | $15.81M(+278.5%) | $596.20M(+4.4%) |
| Jun 2019 | - | $4.18M(+1325.6%) | $570.96M(-15.7%) |
| Mar 2019 | - | $293.00K(-99.9%) | $677.14M(-44.8%) |
| Dec 2018 | $1.23B(>+9900.0%) | $575.91M(-6207.3%) | $1.23B(+88.4%) |
| Sep 2018 | - | -$9.43M(-108.5%) | $651.36M(-1.4%) |
| Jun 2018 | - | $110.36M(-79.9%) | $660.80M(+19.9%) |
| Mar 2018 | - | $550.00M(>+9900.0%) | $551.16M(>+9900.0%) |
| Dec 2017 | $168.00K(-100.0%) | $435.20K(+4044.8%) | $1.64M(+8.3%) |
| Sep 2017 | - | $10.50K(-98.5%) | $1.51M(-2.5%) |
| Jun 2017 | - | $716.00K(+50.7%) | $1.55M(+85.7%) |
| Mar 2017 | - | $475.10K(+53.3%) | $835.00K(+132.0%) |
| Dec 2016 | $472.91M(>+9900.0%) | - | - |
| Dec 2016 | - | $309.90K(+519.8%) | $359.90K(+619.8%) |
| Sep 2016 | - | $50.00K(>+9900.0%) | $50.00K(-95.4%) |
| Jun 2016 | - | $0.00(0.0%) | $1.09M(0.0%) |
| Mar 2016 | - | $0.00(0.0%) | $1.09M(-0.1%) |
| Dec 2015 | $1.10M(-80.8%) | $0.00(-100.0%) | $1.10M(-2.1%) |
| Sep 2015 | - | $1.09M(>+9900.0%) | $1.12M(+5228.6%) |
| Jun 2015 | - | $0.00(-100.0%) | $21.00K(+10.5%) |
| Mar 2015 | - | $1000.00(-95.7%) | $19.00K(-99.7%) |
| Dec 2014 | $5.69M(<-9900.0%) | $23.00K(-866.7%) | $5.69M(+0.3%) |
| Sep 2014 | - | -$3000.00(+50.0%) | $5.68M(+0.0%) |
| Jun 2014 | - | -$2000.00(-100.0%) | $5.68M(+0.0%) |
| Mar 2014 | - | $5.68M(>+9900.0%) | $5.68M(<-9900.0%) |
| Dec 2013 | -$2000.00(-100.1%) | $8000.00(-300.0%) | -$2000.00(-102.3%) |
| Sep 2013 | - | -$4000.00(0.0%) | $86.00K(-4.4%) |
| Jun 2013 | - | -$4000.00(+100.0%) | $90.00K(-295.7%) |
| Mar 2013 | - | -$2000.00(-102.1%) | -$46.00K(-101.8%) |
| Dec 2012 | $2.57M(-84.0%) | $96.00K(>+9900.0%) | $2.57M(-38.6%) |
| Sep 2012 | - | $0.00(-100.0%) | $4.18M(-20.9%) |
| Jun 2012 | - | -$140.00K(-105.4%) | $5.29M(-62.0%) |
| Mar 2012 | - | $2.61M(+52.7%) | $13.93M(-13.1%) |
| Dec 2011 | $16.02M(+28.4%) | $1.71M(+55.0%) | $16.02M(-6.5%) |
| Sep 2011 | - | $1.10M(-87.0%) | $17.14M(+6.4%) |
| Jun 2011 | - | $8.50M(+80.6%) | $16.11M(+51.8%) |
| Mar 2011 | - | $4.71M(+66.3%) | $10.61M(-15.0%) |
| Dec 2010 | $12.48M(+157.1%) | $2.83M(+4189.4%) | $12.48M(+18.4%) |
| Sep 2010 | - | $66.00K(-97.8%) | $10.54M(+0.4%) |
| Jun 2010 | - | $3.01M(-54.3%) | $10.50M(-30.7%) |
| Mar 2010 | - | $6.58M(+640.5%) | $15.15M(+212.2%) |
| Dec 2009 | $4.85M | $888.00K(+2962.1%) | $4.85M(+94.5%) |
| Sep 2009 | - | $29.00K(-99.6%) | $2.50M(+188.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | $7.66M(-305.7%) | $864.00K(-221.5%) |
| Mar 2009 | - | -$3.72M(+153.3%) | -$711.00K(-140.6%) |
| Dec 2008 | $1.75M(-95.7%) | -$1.47M(-8.3%) | $1.75M(-11.7%) |
| Sep 2008 | - | -$1.60M(-126.3%) | $1.99M(-51.3%) |
| Jun 2008 | - | $6.09M(-583.0%) | $4.08M(-378.8%) |
| Mar 2008 | - | -$1.26M(+1.9%) | -$1.46M(-103.6%) |
| Dec 2007 | $41.01M(+157.1%) | -$1.24M(-351.4%) | $41.01M(-12.2%) |
| Sep 2007 | - | $492.00K(-9.1%) | $46.74M(-3.5%) |
| Jun 2007 | - | $541.00K(-98.7%) | $48.41M(-2.5%) |
| Mar 2007 | - | $41.22M(+818.3%) | $49.65M(+211.3%) |
| Dec 2006 | $15.95M(-46.5%) | $4.49M(+107.1%) | $15.95M(+22.9%) |
| Sep 2006 | - | $2.17M(+21.5%) | $12.98M(-65.3%) |
| Jun 2006 | - | $1.78M(-76.2%) | $37.37M(-0.3%) |
| Mar 2006 | - | $7.51M(+395.7%) | $37.48M(+25.8%) |
| Dec 2005 | $29.79M(-56.2%) | $1.51M(-94.3%) | $29.79M(-62.7%) |
| Sep 2005 | - | $26.57M(+1303.3%) | $79.84M(+48.9%) |
| Jun 2005 | - | $1.89M(-1123.2%) | $53.60M(-17.6%) |
| Mar 2005 | - | -$185.00K(-100.4%) | $65.07M(-4.3%) |
| Dec 2004 | $68.00M(+467.8%) | $51.56M(>+9900.0%) | $68.00M(+300.5%) |
| Sep 2004 | - | $328.00K(-97.5%) | $16.98M(-36.3%) |
| Jun 2004 | - | $13.36M(+387.1%) | $26.68M(+76.5%) |
| Mar 2004 | - | $2.74M(+401.5%) | $15.11M(+26.2%) |
| Dec 2003 | $11.97M(+57.9%) | $547.00K(-94.5%) | $11.97M(+1.3%) |
| Sep 2003 | - | $10.02M(+457.8%) | $11.82M(+466.6%) |
| Jun 2003 | - | $1.80M(-558.4%) | $2.09M(+134.6%) |
| Mar 2003 | - | -$392.00K(-200.3%) | $889.00K(-88.3%) |
| Dec 2002 | $7.58M(-41.7%) | $391.00K(+34.8%) | $7.58M(-47.8%) |
| Sep 2002 | - | $290.00K(-51.7%) | $14.54M(-3.7%) |
| Jun 2002 | - | $600.00K(-90.5%) | $15.09M(-1.2%) |
| Mar 2002 | - | $6.30M(-14.1%) | $15.27M(+17.3%) |
| Dec 2001 | $13.02M(>+9900.0%) | $7.34M(+771.1%) | $13.02M(+129.3%) |
| Sep 2001 | - | $843.00K(+8.4%) | $5.68M(+15.5%) |
| Jun 2001 | - | $778.00K(-80.8%) | $4.92M(+20.0%) |
| Mar 2001 | - | $4.05M(>+9900.0%) | $4.10M(+9209.1%) |
| Dec 2000 | $44.00K(-108.8%) | $4000.00(-95.1%) | $44.00K(-173.3%) |
| Sep 2000 | - | $82.00K(-295.2%) | -$60.00K(-88.9%) |
| Jun 2000 | - | -$42.00K(<-9900.0%) | -$542.00K(+8.4%) |
| Mar 2000 | - | $0.00(-100.0%) | -$500.00K(0.0%) |
| Dec 1999 | -$500.00K(-135.7%) | -$100.00K(-75.0%) | -$500.00K(+25.0%) |
| Sep 1999 | - | -$400.00K(<-9900.0%) | -$400.00K(<-9900.0%) |
| Jun 1999 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 1999 | - | $0.00(0.0%) | $1.30M(-7.1%) |
| Dec 1998 | $1.40M(-92.0%) | $0.00(0.0%) | $1.40M(0.0%) |
| Sep 1998 | - | $0.00(-100.0%) | $1.40M(0.0%) |
| Jun 1998 | - | $1.30M(+1200.0%) | $1.40M(+1300.0%) |
| Mar 1998 | - | $100.00K(>+9900.0%) | $100.00K(-99.4%) |
| Dec 1997 | $17.60M(+309.3%) | $0.00(0.0%) | $17.60M(0.0%) |
| Sep 1997 | - | $0.00(0.0%) | $17.60M(+0.6%) |
| Jun 1997 | - | $0.00(-100.0%) | $17.50M(-15.5%) |
| Mar 1997 | - | $17.60M(<-9900.0%) | $20.70M(+567.7%) |
| Dec 1996 | $4.30M(+43.3%) | - | - |
| Sep 1996 | - | -$100.00K(-103.1%) | $3.10M(+3.3%) |
| Jun 1996 | $3.00M(0.0%) | $3.20M(>+9900.0%) | $3.00M(+3.4%) |
| Mar 1996 | - | $0.00(0.0%) | $2.90M(0.0%) |
| Dec 1995 | - | $0.00(-100.0%) | $2.90M(0.0%) |
| Sep 1995 | - | -$200.00K(-106.5%) | $2.90M(-3.3%) |
| Jun 1995 | $3.00M(-37.5%) | $3.10M(>+9900.0%) | $3.00M(-3100.0%) |
| Mar 1995 | - | $0.00(0.0%) | -$100.00K(0.0%) |
| Dec 1994 | - | $0.00(-100.0%) | -$100.00K(-102.2%) |
| Sep 1994 | - | -$100.00K(<-9900.0%) | $4.50M(-6.3%) |
| Jun 1994 | $4.80M | $0.00(0.0%) | $4.80M(0.0%) |
| Mar 1994 | - | $0.00(-100.0%) | $4.80M(0.0%) |
| Dec 1993 | - | $4.60M(+2200.0%) | $4.80M(+2300.0%) |
| Sep 1993 | - | $200.00K | $200.00K |
FAQ
- What is Moderna annual cash flow from financing activities?
- What is the all time high annual CFF for Moderna?
- What is Moderna annual CFF year-on-year change?
- What is Moderna quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Moderna?
- What is Moderna quarterly CFF year-on-year change?
- What is Moderna TTM cash flow from financing activities?
- What is the all time high TTM CFF for Moderna?
- What is Moderna TTM CFF year-on-year change?
What is Moderna annual cash flow from financing activities?
The current annual CFF of MRNA is $56.00M
What is the all time high annual CFF for Moderna?
Moderna all-time high annual cash flow from financing activities is $2.03B
What is Moderna annual CFF year-on-year change?
Over the past year, MRNA annual cash flow from financing activities has changed by +$1.43B (+104.07%)
What is Moderna quarterly cash flow from financing activities?
The current quarterly CFF of MRNA is $4.00M
What is the all time high quarterly CFF for Moderna?
Moderna all-time high quarterly cash flow from financing activities is $1.38B
What is Moderna quarterly CFF year-on-year change?
Over the past year, MRNA quarterly cash flow from financing activities has changed by -$10.00M (-71.43%)
What is Moderna TTM cash flow from financing activities?
The current TTM CFF of MRNA is $46.00M
What is the all time high TTM CFF for Moderna?
Moderna all-time high TTM cash flow from financing activities is $2.03B
What is Moderna TTM CFF year-on-year change?
Over the past year, MRNA TTM cash flow from financing activities has changed by +$867.00M (+105.60%)